PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

PHASE3CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

August 31, 2008

Study Completion Date

February 28, 2010

Conditions
Chronic Hepatitis C
Interventions
DRUG

Pegylated Interferon/ribavirin

Trial Locations (11)

10032

Columbia University Medical Center, New York

19104

Children's Hospital of Philadelphia, Philadelphia

20010

Children's National Medical Center, Washington D.C.

21287

Johns Hopkins University, Baltimore

32610

University of Florida, Gainesville

80218

The Children's Hospital, Denver

98105

Children's Hospital and Regional Medical Center, Seattle

94143-0136

University of California, San Francisco, San Francisco

46202-5225

Indiana University School of Medicine, James Whitcomb Riley Hospital for Children, Indianapolis

02115

Children's Hospital Boston, Boston

45229-3039

Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH